Precision Molecular Pathology of Bladder Cancer
Published on 18. January 2018
Book
Hardback
IX, 243 pages
978-3-319-64767-8 (ISBN)
Description
This succinct yet comprehensive volume describes current and emerging concepts in molecular pathology of bladder cancer. Divided into two distinct sections, the first part focuses on the general principles of molecular findings in bladder cancer, while the second part focuses on the molecular changes associated with specific histologic subtypes. The volume also addresses such topics as molecular alterations in non-invasive and invasive disease, including bladder cancer variants as appropriate, emerging molecular classifiers of bladder cancer, and molecular associations to outcome and treatment. Written by experts in the field, Precision Molecular Pathology of Bladder Cancer is a valuable resource for those in the urologic community, including urologic pathologists, urologists, urologic oncologists and radiation oncologists, who treat and manage bladder cancer.
More details
Series
Edition
2018 ed.
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
2 s/w Abbildungen, 38 farbige Abbildungen
IX, 243 p. 40 illus., 38 illus. in color.
Dimensions
Height: 241 mm
Width: 160 mm
Thickness: 19 mm
Weight
599 gr
ISBN-13
978-3-319-64767-8 (9783319647678)
DOI
10.1007/978-3-319-64769-2
Schweitzer Classification
Other editions
Additional editions
Donna E. Hansel | Seth P. Lerner
Precision Molecular Pathology of Bladder Cancer
Book
06/2019
Springer
€106.99
Shipment within 10-15 days
Donna E. Hansel | Seth P. Lerner
Precision Molecular Pathology of Bladder Cancer
E-Book
01/2018
1st Edition
Springer
€96.29
Available for download
Persons
Donna E. Hansel MD PhDProfessor, UCSD Department of PathologyChief, Division of Anatomic Pathology9500 Gilman Drive, MC 0612La Jolla, CA 92093
Seth P. Lerner, MD, FACSProfessor, Scott Department of UrologyBeth and Dave Swalm Chair in Urologic Oncology Director of Urologic OncologyDirector of the Multidisciplinary Bladder Cancer ProgramFaculty Group Practice Medical Director Co-Editor in Chief Bladder CancerBaylor College of Medicine Medical Center7200 Cambridge, MC BCM380 Houston, Texas 77030
Seth P. Lerner, MD, FACSProfessor, Scott Department of UrologyBeth and Dave Swalm Chair in Urologic Oncology Director of Urologic OncologyDirector of the Multidisciplinary Bladder Cancer ProgramFaculty Group Practice Medical Director Co-Editor in Chief Bladder CancerBaylor College of Medicine Medical Center7200 Cambridge, MC BCM380 Houston, Texas 77030
Content
1.Risk Factors and Molecular Features Associated with Bladder Cancer Development.- 2.Grading, Staging, and Morphologic Risk Stratification of Bladder Cancer.- 3.Genomic Assessment of Muscle-Invasive Bladder Cancer: Insights from The Cancer Genome Atlas (TCGA) Project.- 4.Molecular Alterations in the Pathogenesis of Bladder Cancer Subtypes and Urothelial Carcinoma Variants.- 5.Treatment Paradigms in Bladder Cancer: Clinical Implications of Histological and Molecular Analysis.- 6.Requisite for Collection and Distribution of Tissue and Fluid Specimens for Molecular Diagnostics and Discovery in Bladder Cancer.- 7.Diagnostic, Prognostic and Predictive Biomarkers on Bladder Tissue and Blood.- 8.Urine Cytology and Existing Urinary Biomarkers for Bladder Cancer.- 9.Molecular Targeted Therapy of Bladder Cancer.- 10.Response to Immunotherapy: Application of Molecular Pathology to Predict Successful Response.- 11.Emerging Molecular Approaches in the Analysis of Urine in Bladder Cancer Diagnosis.- 12. Stromal Contributions to Tumor Progression in Urothelial Carcinoma of the Bladder.- 13.Modeling Bladder Cancer with Genetic Engineering: Fidelity of Human-to-laboratory Models.